CyberHeart Secures $9 Million in Series A Financing

MENLO PARK, Calif.--(BUSINESS WIRE)--CyberHeart Incorporated, a Menlo Park, Calif-based medical device company developing the first totally non-invasive system to treat cardiac arrhythmias, today announced the close of a $9 million Series A financing. The investment was co-led by Emergent Medical Ventures, LLP (Portola Valley, Calif.) and United Investments (Taipei, Taiwan). Also participating in the round were Venture Select GmbH (Munich, Germany) and Mitsubishi Corporation (New York, NY).